Clinical Trial Update: Zinc-L-Carnosine Prevents Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial suggesting zinc-L-carnosine may prevent dysphagia in breast cancer patients undergoing adjuvant radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zinc-L-carnosine (zinc-L-carnosine)

Snippet

Sponsor: Cynthia Aristei | Conditions: Breast Cancer Female, Dysphagia | Phase 3 | Status: COMPLETED